A Multicenter Study of a Fluorescence In Situ Hybridization Probe Set for Diagnosing High-Grade Dysplasia and Adenocarcinoma in Barrett’s Esophagus

被引：0

作者：

John M. Poneros

Adam S. Faye

Emily G. Barr Fritcher

Ananda Sen

Sharmila Anandasabapathy

Robert S. Bresalier

Norman Marcon

D. Kim Turgeon

Henry Appelman

Daniel Normolle

Larry E. Morrison

Dean E. Brenner

Kevin C. Halling

机构：

[1] Columbia University Medical Center,Department of Gastroenterology

[2] Columbia University Medical Center,Department of Internal Medicine

[3] Mayo Clinic,Department of Laboratory Medicine and Pathology

[4] University of Michigan Medical Center,Department of Biostatistics

[5] Baylor St. Luke’s Medical Center Clinic,Department of Gastroenterology, Baylor College of Medicine

[6] University of Texas M.D. Anderson Cancer Center,Department of Gastroenterology

[7] University of Toronto,Department of Gastroenterology

[8] University of Michigan Medical Center,Department of Internal Medicine

[9] University of Michigan Medical Center,Department of Pathology

[10] University of Pittsburgh Cancer Institute,Department of Biostatistics

[11] Abbott Molecular,Department of Pharmacology

[12] Inc.,Department of Family Medicine

[13] University of Michigan Medical Center,St. Michael’s Hospital

[14] Ventana Medical Systems Inc.,Department of Gastroenterology

[15] University of Michigan Medical School,undefined

[16] University of Toronto,undefined

[17] University of Michigan Health System,undefined

来源：

Digestive Diseases and Sciences | 2017年 / 62卷

关键词：

Barrett’s esophagus; Dysplasia; Histopathology; Endoscopy; FISH; Polysomy;

D O I：

暂无

中图分类号：

学科分类号：

摘要：

引用

页码：1216 / 1222

页数：6

共 58 条

[1] Devesa SS(1998)Changing patterns in the incidence of esophageal and gastric carcinoma in the United States Cancer 83 2049-2053
[2] Blot WJ(2003)Trends in survival for both histologic types of esophageal cancer in US surveillance, epidemiology and end results areas Int J Cancer 105 98-100
[3] Fraumeni JF(2005)The role of overdiagnosis and reclassification in the marked increase of esophageal adenocarcinoma incidence J Natl Cancer Inst 97 142-146
[4] Polednak AP(2013)Epidemiology of esophageal cancer World J Gastroenterol 19 5598-5606
[5] Pohl H(2003)Esophageal cancer N Engl J Med 349 2241-2252
[6] Welch HG(2009)Adherence to biopsy guidelines for Barrett’s esophagus surveillance in the community setting in the United States Clin Gastroenterol Hepatol 7 736-742
[7] Zhang Y(2005)Dysplasia in Barrett’s esophagus: limitations of current management strategies Am J Gastroenterol 100 927-935
[8] Enzinger PC(1988)Endoscopic biopsy can detect high-grade dysplasia or early adenocarcinoma in Barrett’s esophagus without grossly recognizable neoplastic lesions Gastroenterology 94 81-90
[9] Mayer RJ(1988)Observer variation in the diagnosis of dysplasia in Barrett’s esophagus Hum Pathol 19 166-178
[10] Abrams JA(2001)Reproducibility of the diagnosis of dysplasia in Barrett esophagus: a reaffirmation Hum Pathol 32 368-378